Literature DB >> 23960983

Update on lacrimal gland neoplasms: Molecular pathology of interest.

Valerie A White1.   

Abstract

Lacrimal gland neoplasms are rare and much of our knowledge of the behavior and molecular pathogenesis of these tumors comes from study of the similar, but more numerous salivary gland neoplasms. After briefly discussing the classification of lacrimal gland neoplasms, I review three areas of emerging knowledge in the pathogenesis of these neoplasms: (1) the concept of adenoid cystic carcinoma with high-grade transformation and the associated cytogenetic changes; (2) recent analysis of the MYB-NFIB gene fusion in adenoid cystic carcinoma, and; (3) overexpression of HER2 in malignant salivary and lacrimal neoplasms.

Entities:  

Keywords:  Lacrimal gland neoplasms; Molecular pathogenesis

Year:  2012        PMID: 23960983      PMCID: PMC3729628          DOI: 10.1016/j.sjopt.2012.02.012

Source DB:  PubMed          Journal:  Saudi J Ophthalmol        ISSN: 1319-4534


  11 in total

1.  Progressive genetic alterations of adenoid cystic carcinoma with high-grade transformation.

Authors:  Raja R Seethala; Kathleen Cieply; E Leon Barnes; Sanja Dacic
Journal:  Arch Pathol Lab Med       Date:  2011-01       Impact factor: 5.534

2.  Genetic and expression analysis of HER-2 and EGFR genes in salivary duct carcinoma: empirical and therapeutic significance.

Authors:  Michelle D Williams; Dianna B Roberts; Merrill S Kies; Li Mao; Randal S Weber; Adel K El-Naggar
Journal:  Clin Cancer Res       Date:  2010-04-06       Impact factor: 12.531

3.  Epithelial lacrimal gland tumors: pathologic classification and current understanding.

Authors:  Ezekiel Weis; Jack Rootman; Thomas J Joly; Kenneth W Berean; Hind M Al-Katan; Sylvia Pasternak; Giulio Bonavolontà; Diego Strianese; Peerooz Saeed; Kenneth A Feldman; Sumalee Vangveeravong; Jocelyne S Lapointe; Valerie A White
Journal:  Arch Ophthalmol       Date:  2009-08

Review 4.  Histologic grading and prognostic biomarkers in salivary gland carcinomas.

Authors:  Raja R Seethala
Journal:  Adv Anat Pathol       Date:  2011-01       Impact factor: 3.875

5.  MYB expression and translocation in adenoid cystic carcinomas and other salivary gland tumors with clinicopathologic correlation.

Authors:  Robert B West; Christina Kong; Nicole Clarke; Thea Gilks; Joe S Lipsick; Hongbin Cao; Shirley Kwok; Kelli D Montgomery; Sushama Varma; Quynh-Thu Le
Journal:  Am J Surg Pathol       Date:  2011-01       Impact factor: 6.394

6.  Comprehensive analysis of the MYB-NFIB gene fusion in salivary adenoid cystic carcinoma: Incidence, variability, and clinicopathologic significance.

Authors:  Yoshitsugu Mitani; Jie Li; Pulivarthi H Rao; Yi-Jue Zhao; Diana Bell; Scott M Lippman; Randal S Weber; Carlos Caulin; Adel K El-Naggar
Journal:  Clin Cancer Res       Date:  2010-08-11       Impact factor: 12.531

Review 7.  Prognostic factors in malignant tumours of the salivary glands.

Authors:  Paul M Speight; A William Barrett
Journal:  Br J Oral Maxillofac Surg       Date:  2009-05-05       Impact factor: 1.651

8.  Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck.

Authors:  Marta Persson; Ywonne Andrén; Joachim Mark; Hugo M Horlings; Fredrik Persson; Göran Stenman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-19       Impact factor: 11.205

9.  Cytogenetic findings in seven lacrimal gland neoplasms.

Authors:  M Hrynchak; V White; K Berean; D Horsman
Journal:  Cancer Genet Cytogenet       Date:  1994-07-15

10.  Fluorescence in situ hybridization gene amplification analysis of EGFR and HER2 in patients with malignant salivary gland tumors treated with lapatinib.

Authors:  Laura Vidal; Ming S Tsao; Gregory R Pond; Ezra E W Cohen; Roger B Cohen; Eric X Chen; Mark Agulnik; Sebastien Hotte; Eric Winquist; Scott Laurie; D Neil Hayes; James Ho; Janet Dancey; Lillian L Siu
Journal:  Head Neck       Date:  2009-08       Impact factor: 3.147

View more
  4 in total

1.  Adjuvant Radiotherapy with Three-Dimensional Conformal Radiotherapy of Lacrimal Gland Adenoid Cystic Carcinoma.

Authors:  Vikas Roshan; Sushmita Pathy; Supriya Mallick; Subhash Chander; Seema Sen; Bhavna Chawla
Journal:  J Clin Diagn Res       Date:  2015-10-01

2.  Metastatic, her-2 amplified lacrimal gland carcinoma with response to lapatinib treatment.

Authors:  Trevor Dennie
Journal:  Case Rep Oncol Med       Date:  2015-02-02

3.  miR-24-3p Suppresses Malignant Behavior of Lacrimal Adenoid Cystic Carcinoma by Targeting PRKCH to Regulate p53/p21 Pathway.

Authors:  Ming-Xue Zhang; Jie Zhang; Hong Zhang; Hua Tang
Journal:  PLoS One       Date:  2016-06-28       Impact factor: 3.240

4.  Lacrimal gland adenocarcinoma responding to checkpoint inhibition and androgen deprivation.

Authors:  Ajaz Bulbul
Journal:  Oxf Med Case Reports       Date:  2018-08-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.